Aclaris Therapeutics (ACRS) Return on Assets (2017 - 2025)
Historic Return on Assets for Aclaris Therapeutics (ACRS) over the last 9 years, with Q3 2025 value amounting to 0.8%.
- Aclaris Therapeutics' Return on Assets fell 5700.0% to 0.8% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.8%, marking a year-over-year decrease of 5700.0%. This contributed to the annual value of 0.63% for FY2024, which is 2400.0% down from last year.
- According to the latest figures from Q3 2025, Aclaris Therapeutics' Return on Assets is 0.8%, which was down 5700.0% from 0.71% recorded in Q2 2025.
- Aclaris Therapeutics' 5-year Return on Assets high stood at 0.21% for Q2 2021, and its period low was 0.8% during Q3 2025.
- In the last 5 years, Aclaris Therapeutics' Return on Assets had a median value of 0.35% in 2024 and averaged 0.42%.
- As far as peak fluctuations go, Aclaris Therapeutics' Return on Assets surged by 3100bps in 2024, and later plummeted by -5700bps in 2025.
- Over the past 5 years, Aclaris Therapeutics' Return on Assets (Quarter) stood at 0.35% in 2021, then rose by 1bps to 0.34% in 2022, then dropped by -30bps to 0.45% in 2023, then crashed by -49bps to 0.67% in 2024, then fell by -20bps to 0.8% in 2025.
- Its last three reported values are 0.8% in Q3 2025, 0.71% for Q2 2025, and 0.64% during Q1 2025.